8-K
Current Report
Viridian Therapeutics, Inc.\DE Filed Acc 0001590750-19-000006
Executive or director change
- Item 5.02 Departure or appointment of directors or officers
From the SEC's structured data for this filing
Loading mgen8k-executivecomp.htm…